Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Rutendo E. Mapengo"'
Autor:
Kelsey A. Pilewski, Steven Wall, Simone I. Richardson, Nelia P. Manamela, Kaitlyn Clark, Tandile Hermanus, Elad Binshtein, Rohit Venkat, Giuseppe A. Sautto, Kevin J. Kramer, Andrea R. Shiakolas, Ian Setliff, Jordan Salas, Rutendo E. Mapengo, Naveen Suryadevara, John R. Brannon, Connor J. Beebout, Rob Parks, Nagarajan Raju, Nicole Frumento, Lauren M. Walker, Emilee Friedman Fechter, Juliana S. Qin, Amyn A. Murji, Katarzyna Janowska, Bhishem Thakur, Jared Lindenberger, Aaron J. May, Xiao Huang, Salam Sammour, Priyamvada Acharya, Robert H. Carnahan, Ted M. Ross, Barton F. Haynes, Maria Hadjifrangiskou, James E. Crowe, Jr., Justin R. Bailey, Spyros Kalams, Lynn Morris, Ivelin S. Georgiev
Publikováno v:
Cell Reports, Vol 42, Iss 2, Pp 112044- (2023)
Summary: Despite prolific efforts to characterize the antibody response to human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV) mono-infections, the response to chronic co-infection with these two ever-evolving viruses is poorly un
Externí odkaz:
https://doaj.org/article/1510f5933b314ee292c1c7de93695a93
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 16, Iss 9 (2022)
Background Emergomycosis, histoplasmosis, sporotrichosis and blastomycosis are endemic to southern Africa; the first two are AIDS-related mycoses. We described laboratory-diagnosed cases of endemic and imported mycoses in South Africa over a decade a
Externí odkaz:
https://doaj.org/article/3d444abea9db4b97bd3f7a48cfcd4775
Autor:
Peter B. Gilbert, Yunda Huang, Allan C. deCamp, Shelly Karuna, Yuanyuan Zhang, Craig A. Magaret, Elena E. Giorgi, Bette Korber, Paul T. Edlefsen, Raabya Rossenkhan, Michal Juraska, Erika Rudnicki, Nidhi Kochar, Ying Huang, Lindsay N. Carpp, Dan H. Barouch, Nonhlanhla N. Mkhize, Tandile Hermanus, Prudence Kgagudi, Valerie Bekker, Haajira Kaldine, Rutendo E. Mapengo, Amanda Eaton, Elize Domin, Carley West, Wenhong Feng, Haili Tang, Kelly E. Seaton, Jack Heptinstall, Caroline Brackett, Kelvin Chiong, Georgia D. Tomaras, Philip Andrew, Bryan T. Mayer, Daniel B. Reeves, Magdalena E. Sobieszczyk, Nigel Garrett, Jorge Sanchez, Cynthia Gay, Joseph Makhema, Carolyn Williamson, James I. Mullins, John Hural, Myron S. Cohen, Lawrence Corey, David C. Montefiori, Lynn Morris
Publikováno v:
Nature medicine. 28(9)
The Antibody Mediated Prevention trials showed that the broadly neutralizing antibody (bnAb) VRC01 prevented acquisition of human immunodeficiency virus-1 (HIV-1) sensitive to VRC01. Using AMP trial data, here we show that the predicted serum neutral
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::922789407a8a56e01767022be6aee134
https://pubmed.ncbi.nlm.nih.gov/35995954
https://pubmed.ncbi.nlm.nih.gov/35995954
Autor:
Rutendo E. Mapengo, Abdullah Ely, Bronwen E. Lambson, Tristan A. Scott, Lorraine Z. Mutsvunguma, Stuart A. Ali, Alejandro B. Balazs, Nigel A. Makoah, Lynn Morris, Salim S. Abdool Karim, Fiona T. van den Berg, Nonhlanhla N. Mkhize, Prudence Kgagudi, Marc S. Weinberg, Patrick Arbuthnot, Carol Crowther
Publikováno v:
Molecular Therapy. Methods & Clinical Development
HIV-1 infection continues to be a global health challenge and a vaccine is urgently needed. Broadly neutralizing antibodies (bNAbs) are considered essential as they inhibit multiple HIV-1 strains, but they are difficult to elicit by conventional immu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f4cd55609208b5a0527a368f728e4d2
https://pubmed.ncbi.nlm.nih.gov/31334303
https://pubmed.ncbi.nlm.nih.gov/31334303
Autor:
Charissa Oosthuysen, Andrea R. Shiakolas, Ivelin S. Georgiev, Priyamvada Acharya, Kelsey A. Pilewski, Rutendo E. Mapengo, Mark Connors, Daniel Lingwood, Ian Setliff, Lynn Morris, Juliana S. Qin, Barney S. Graham, Katarzyna Janowska, Amyn A. Murji, Allison R. Greenplate, Masaru Kanekiyo, Kevin J Kramer, Nagarajan Raju, Larance Ronsard, Simone I. Richardson, Wyatt J. McDonnell
Publikováno v:
Cell
B cell receptor (BCR) sequencing is a powerful tool for interrogating immune responses to infection and vaccination, but it provides limited information about the antigen specificity of the sequenced BCRs. Here, we present LIBRA-seq (linking B cell r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6acc4a420fc7616d42ea5875e7fe04a
https://doi.org/10.1016/j.cell.2019.11.003
https://doi.org/10.1016/j.cell.2019.11.003
Autor:
Nonhlanhla N Mkhize, Anna E J Yssel, Haajira Kaldine, Rebecca T van Dorsten, Amanda S Woodward Davis, Nicolas Beaume, David Matten, Bronwen Lambson, Tandile Modise, Prudence Kgagudi, Talita York, Dylan H Westfall, Elena E Giorgi, Bette Korber, Colin Anthony, Rutendo E Mapengo, Valerie Bekker, Elizabeth Domin, Amanda Eaton, Wenjie Deng, Allan DeCamp, Yunda Huang, Peter B Gilbert, Asanda Gwashu-Nyangiwe, Ruwayhida Thebus, Nonkululeko Ndabambi, Dieter Mielke, Nyaradzo Mgodi, Shelly Karuna, Srilatha Edupuganti, Michael S Seaman, Lawrence Corey, Myron S Cohen, John Hural, M Juliana McElrath, James I Mullins, David Montefiori, Penny L Moore, Carolyn Williamson, Lynn Morris
Publikováno v:
PLoS Pathogens, Vol 19, Iss 6, p e1011469 (2023)
The VRC01 Antibody Mediated Prevention (AMP) efficacy trials conducted between 2016 and 2020 showed for the first time that passively administered broadly neutralizing antibodies (bnAbs) could prevent HIV-1 acquisition against bnAb-sensitive viruses.
Externí odkaz:
https://doaj.org/article/1a870a5047ec41f0af5508300c65082a